Fusek I, Vorreith M
Zentralbl Neurochir. 1976;37(1):45-50.
The present results allow to make the following conclusions: (1) In the case of relapses or progressions of intracranial gliomata, reoperation usually yields unsatisfactory therapeutical results, often leading even to premature death of the patient. (2) Reoperations for intracranial gliomata should be decided individually. Determining their indication are the size, location, and histological character ascertained during the first intervention. Also, it is necessary to give detailed consideration to the results of both scintigraphic and angiographic examinations, which give an idea of the actual size of proliferation. (3) Relapses of malignant and relatively malignant gliomata are not reoperable. (4) Showing a relative capability of treatment by surgical reoperation are relapses of benign gliomata in functionally unimportant regions, which do not affect remote cerebral structures and which are accompanied by intracranial hypertension. (5) Reoperation is absolutely indicated in the case of relapses of spongioblastomata of the cerebellum providing the tumor does not affect the brain-stem.
(1) 对于颅内胶质瘤复发或进展的情况，再次手术通常产生不尽人意的治疗效果，甚至常常导致患者过早死亡。(2) 颅内胶质瘤再次手术应个体化决定。首次干预时确定的肿瘤大小、位置和组织学特征决定了再次手术的指征。此外，有必要仔细考虑闪烁扫描和血管造影检查的结果，这些检查可了解增殖的实际大小。(3) 恶性和相对恶性胶质瘤的复发不宜再次手术。(4) 功能不重要区域的良性胶质瘤复发，若不影响远处脑结构且伴有颅内高压，显示出通过手术再次治疗的相对可行性。(5) 小脑成胶质细胞瘤复发时，若肿瘤不影响脑干，则绝对需要再次手术。
